Detalhe da pesquisa
1.
A multi-dimensional integrative scoring framework for predicting functional variants in the human genome.
Am J Hum Genet
; 109(3): 446-456, 2022 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35216679
2.
Considerations for master protocols using external controls.
J Biopharm Stat
; : 1-23, 2024 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38363805
3.
Duration of and time to response in oncology clinical trials from the perspective of the estimand framework.
Pharm Stat
; 23(1): 91-106, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37786317
4.
Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma.
Blood
; 137(26): 3616-3628, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33763699
5.
Estimation of conditional power in the presence of auxiliary data.
Stat Med
; 42(24): 4319-4332, 2023 10 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37493067
6.
Estimands for overall survival in clinical trials with treatment switching in oncology.
Pharm Stat
; 21(1): 150-162, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34605168
7.
Sample size and power for the weighted log-rank test and Kaplan-Meier based tests with allowance for nonproportional hazards.
Biometrics
; 76(3): 939-950, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31797363
8.
Validity of using ad hoc methods to analyze secondary traits in case-control association studies.
Genet Epidemiol
; 40(8): 732-743, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27670932
9.
Impact of concomitant dexamethasone dosing schedule on bortezomib-induced peripheral neuropathy in multiple myeloma.
Br J Haematol
; 178(5): 756-763, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28591409
10.
Tumor-Agnostic Approvals: Insights and Practical Considerations.
Clin Cancer Res
; 30(3): 480-488, 2024 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37792436
11.
Rolling continual reassessment method with overdose control: An efficient and safe dose escalation design.
Contemp Clin Trials
; 107: 106436, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34000410
12.
Assessing the Impact of COVID-19 on the Clinical Trial Objective and Analysis of Oncology Clinical Trials-Application of the Estimand Framework.
Stat Biopharm Res
; 12(4): 427-437, 2020 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34191975
13.
Novel structural co-expression analysis linking the NPM1-associated ribosomal biogenesis network to chronic myelogenous leukemia.
Sci Rep
; 5: 10973, 2015 Jul 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26205693
14.
Association between response kinetics and outcomes in relapsed/refractory multiple myeloma: analysis from TOURMALINE-MM1.
Leukemia
; 32(9): 2032-2036, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29568098